Michael Krepps
Venture Partner at Global BioAccess Fund
About
Mike Krepps joined the Global BioAccess Fund in 2023 as a Venture Partner and also serves as Chief Strategy Officer for AI Proteins. He previously was COO of the immunotherapy biotech OncoPep, led the investment team at the American Cancer Society's VC fund BrightEdge, and worked as an Associate Principal in CRA's Life Sciences Practice. His background also includes co-founding SynActive Biosciences and serving as a Program Manager/Senior Scientist at the US Department of Defense's Biosciences Division. He holds an MS in genetics and a BS in Bacteriology from the University of Wisconsin-Madison and an MBA from the University of Chicago Booth School of Business.
Invests in
Biotech
Colleagues at Global BioAccess Fund
Bruce Roberts
Managing Partner at Global BioAccess Fund
Dave Praharaj
Senior Associate at Global BioAccess Fund
Dave Praharaj, MD
Senior Associate at Global BioAccess Fund
Kevin Cyr
Research Associate at Global BioAccess Fund
Kevin Cyr, MD
Research Associate at Global BioAccess Fund
Lisa Wisniewski
Managing Director at Global BioAccess Fund
Lisa Wisniewski, PhD
Managing Director at Global BioAccess Fund
Sonia Gulati
Principal at Global BioAccess Fund